Effect of Adjuvant Therapy by Sorafenib, Oxaliplatin and S-1
Status:
Withdrawn
Trial end date:
2019-12-01
Target enrollment:
Participant gender:
Summary
The study is designed to investigate the effect of adjuvant therapy by Sorafenib, Oxaliplatin
and S-1 to prevent the tumor recurrence for hepatocellular carcinoma after liver
transplantation